Search for: "TEVA USA, INC." Results 561 - 580 of 646
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2015, 12:00 pm by Greene LLP
In March 2014, Teva Pharmaceuticals USA Inc. and IVAX LLC, paid the federal government and the state of Illinois $27.6 million to settle allegations that they violated the state and federal False Claims Acts by making payments to Reinstein in return for him prescribing clozapine to his patients. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
30 May 2012, 8:28 am by Michelle Yeary
Teva Pharmaceuticals USA, Inc., 2012 U.S. [read post]
5 May 2010, 10:14 pm
USA, Inc., 583 F.3d 766, 777 (Fed. [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
Skinny Label Infringement in Teva Pharmaceuticals USA, Inc. v. [read post]
23 Aug 2012, 12:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2010 WL 8357563, slip op. at 1-2 (Tex. [read post]
24 Jul 2009, 1:49 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense. [read post]
6 Apr 2011, 12:18 am by Marie Louise
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog)  Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
28 May 2010, 11:51 pm
USA, Inc., 418 F.3d 1326, 1348 (Fed. [read post]
5 Apr 2011, 2:35 pm by FDABlog HPM
  Par opposed the Motion to Dismiss arguing that pursuant to the Federal Circuit’s decision in Teva Pharmaceuticals USA, Inc. v. [read post]
14 Jun 2011, 12:21 pm by John Elwood
Teva Pharmaceuticals USA, Inc., 10-1070, in which the Court had relisted twice and called for a response. [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]